| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 34 |
| 1 | DUPILUMAB | 32 |
| 2 | ADALIMUMAB | 31 |
| 3 | FOLIC ACID | 28 |
| 4 | LEVOTHYROXINE SODIUM | 28 |
| 5 | PREDNISONE | 28 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 26 |
| 7 | TACROLIMUS OINTMENT 0.1% | 26 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 22 |
| 9 | ACETAMINOPHEN | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUMASIRAN | 2 | 0.0052 |
| 1 | EPHEDRINE SULFATE | 1 | 0.0046 |
| 2 | EPHEDRINE HYDROCHLORIDE | 1 | 0.0022 |
| 3 | CHLOROTHIAZIDE SODIUM | 2 | 0.0022 |
| 4 | DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | 1 | 0.0019 |
| 5 | TRIHEPTANOIN | 1 | 0.0018 |
| 6 | XYLOMETAZOLINE HYDROCHLORIDE | 1 | 0.0018 |
| 7 | SILICON DIOXIDE | 1 | 0.0016 |
| 8 | CHLOROTHIAZIDE | 2 | 0.0016 |
| 9 | I. V. FAT EMULSION | 1 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 64 |
| 1 | Vitamin C [EPC] | 39 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 34 |
| 3 | Vitamin D [EPC] | 33 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 32 |
| 5 | Vitamin B12 [EPC] | 32 |
| 6 | Benzodiazepine [EPC] | 26 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 23 |
| 8 | Proton Pump Inhibitor [EPC] | 20 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 1 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 2 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Calcitonin [EPC] | 1 | 0.0003 |
| 5 | Melatonin Receptor Agonist [EPC] | 4 | 0.0003 |
| 6 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 7 | Vitamin K [EPC] | 2 | 0.0002 |
| 8 | Calcitonin Gene-related Peptide Antagonist [EPC] | 2 | 0.0002 |
| 9 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |